Publication|Articles|March 4, 2026
Supplements and Featured Publications
- The Cost of PCSK9 mAb Waste: Results From a Patient-Reported Survey on PCSK9 mAb Compliance and Discontinuation
The Cost of PCSK9 mAb Waste: Results From a Patient-Reported Survey on PCSK9 mAb Compliance and Discontinuation
Key Takeaways
Advertisement
This clinical brief is sponsored by Novartis.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
3
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
4
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
5